Federated Hermes Inc. boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 34.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,728 shares of the medical research company’s stock after purchasing an additional 15,871 shares during the period. Federated Hermes […]